期刊文献+

p16,Cyclin D1在胃癌发生过程中的表达 被引量:12

Expression of p16 and Cyclin D1 in Carcinogenesis of Stomach
下载PDF
导出
摘要 目的:研究p16,CyclinD1在胃癌发生过程中的表达。方法:采用免疫组化ABC法,检测胃癌、不典型增生、萎缩性胃炎及正常胃粘膜组织p16和CyclinD1的表达。结果:p16蛋白在正常胃粘膜表达率最高(867%,13/15),并随病变进展(浅表性胃炎-萎缩性胃炎-不典型增生-腺癌),表达率呈下降趋势(分别为85%;786%;318%;483%),其中不典型增生、腺癌组与正常组比较差异显著(P<005)。CyclinD1过度表达在萎缩性胃炎即已出现,并随病变发展表达率升高,萎缩性胃炎、不典型增生、腺癌的CyclinD1蛋白表达率分别为179%(5/28);364%(8/22);534%(31/58),其中腺癌与萎缩性胃炎差异显著(P<005)。相关性分析显示,大多数受检胃癌组织中,p16与CyclinD1呈反向表达。结论:p16和CyclinD1在胃上皮癌变过程中起着重要作用,其在胃癌中的反向表达趋势提示两者可能存在相互抑制机制。 p16 and Cyclin D1 expressions were determined in the specimens of gastric carcinoma, atypical hyperplasia, atrophic gastritis, superficial gastritis and normal gastric mucosa by using immunohistochemical method ABC).The results showed that positive immunostaining rate for p16 protein was the highest in normal gastric mucosa and decreased with progression from superficial gastritis to atrophic gastritis to atypical hyperplasia and to adenocarcinoma (85%, 78.6%, 31.8%, 48.3%respectively). Positive immunostaining of cyclin D1 could be observed in atrophic gastritis with the lesions progressing from atrophic gastitis to atypial hyperplasia and to adenocarcinoma, the expression rates increased in order 17.9%, 36.4%, 53.4%respectively. There was a significant difference between adenocarcinoma and atrophic gastritis group (P< 0.05). An interesting observation was that inverse expression between p16 and Cyclin D1 was shown in most of the gastric cancer tested. The results suggest that p16 and Cyclin D1 play an important role in gastric carcinogenesis, and that the inverse expression between p16 and Cyclin D1 suggests antagonism between the two.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1999年第2期98-100,共3页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金
关键词 胃肿瘤 P16基因 CYCLIND1 基因表达 p16 Cyclin D1 Gastric cancer Carcinogenesis
  • 相关文献

参考文献3

二级参考文献2

  • 1程金泉,Cancer Res,1994年,54卷,5547页
  • 2Li Ju,Semi Surg Oncol,1994年,10卷,95页

共引文献113

同被引文献50

  • 1张锦坤,于君.癌基因ras产物P^(21)蛋白在胃癌及癌前病变的表达[J].中国肿瘤临床,1994,21(12):901-902. 被引量:11
  • 2余应年.癌基因/抑癌基因与细胞增殖控制[J].实用肿瘤杂志,1995,10(1):6-8. 被引量:8
  • 3吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 4刘国魁,熊晨,宋学平.p16、cyclinD1在胃癌及癌前病变中表达与胃癌的关系[J].白求恩军医学院学报,2007,5(3):157-159. 被引量:4
  • 5张荫昌 刘复生 等.胃及贲门癌.肿瘤病理学(第1版)[M].北京:北京医科大学、中国协和医科大学联合出版社,1997.705-789.
  • 6吴强 郑国豪 王保太 等.乳腺癌类固醇激素受体的临床病理研究.中华病理学杂志,1989,18(4):247-247.
  • 7Hunter T, Pines J. Cyclins and cancer II :cyclin D and CDK inhibitors come of age[J]. Cell, 1994,79(6) : 573.
  • 8Lukas J, Pagano M, Staskova Z,et al. cyclinD1 protein oscillates and is essential for cell cycle progression in human tumor cell lines[J]. Oncogene, 1994,9 : 707.
  • 9Arber N, Marilie, Gammon, et al. overexpression of cyclinD1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach[J]. Humanpathology, 1999,30(9) : 1087--1092.
  • 10Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366(6456):704

引证文献12

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部